124B.2 REPORTING REQUIRED.
1. Effective July 1, 1990, a report to the board shall be
submitted in accordance with this chapter by a manufacturer,
retailer, or other person who sells, transfers, or otherwise
furnishes to any person in this state any of the following
substances:
a. Anthranilic acid, its esters, and its salts.
b. Benzyl cyanide.
c. Ethylamine and its salts.
d. Ergonovine and its salts.
e. Ergotamine and its salts.
f. 3,4 - methylenedioxyphenyl-2-propanone.
g. N-acetylanthranilic acid, its esters, and its salts.
h. Norpseudoephedrine, its salts, optical isomers, and salts
of optical isomers.
i. Phenylacetic acid, its esters, and its salts.
j. Piperidine and its salts.
k. Methylamine and its salts.
l. Propionic anhydride.
m. Isosafrole.
n. Safrole.
o. Piperonal.
p. N-methylephedrine, its salts, optical isomers, and salts
of optical isomers.
q. N-methylpseudoephedrine, its salts, optical isomers, and
salts of optical isomers.
r. Hydriodic acid.
s. Benzaldehyde.
t. Nitroethane.
u. Gamma-Butyrolactone (also known as
GBL; Dihydro-2(3H)-furanone; 1,2-Butanolide;
1,4-Butanolide; 4-Hydroxybutanoic acid lactone;
or gamma-hydroxy-butyric acid lactone).
v. Red phosphorus.
w. White phosphorus (another name: yellow phosphorus).
x. Hypophosphorous acid and its salts (including ammonium
hypophosphite, calcium hypophosphite, iron hypophosphite, potassium
hypophosphite, manganese hypophosphite, magnesium hypophosphite, and
sodium hypophosphite).
y. Iodine.
z. N-phenethyl-4-piperidone (NPP).
2. The board shall administer the regulatory provisions of this
chapter and may, by rule adopted pursuant to chapter 17A, add a
substance to or remove a substance from the list in subsection 1. In
determining whether to add or remove a substance from the list, the
board shall consider the following:
a. The likelihood that the substance may be used as a
precursor in the illegal production of a controlled substance.
b. The availability of the substance.
c. The appropriateness of including the substance under this
chapter or under chapter 124.
d. The extent and nature of legitimate uses for the
substance.
3. On or before November 1 of each year, the board shall inform
the general assembly of any substances added, deleted, or changed in
the list contained in this section and shall provide an explanation
of any addition, deletion, or change.
124B.2 REPORTING REQUIRED.
1. Effective July 1, 1990, a report to the board shall be
submitted in accordance with this chapter by a manufacturer,
retailer, or other person who sells, transfers, or otherwise
furnishes to any person in this state any of the following
substances:
a. Anthranilic acid, its esters, and its salts.
b. Benzyl cyanide.
c. Ethylamine and its salts.
d. Ergonovine and its salts.
e. Ergotamine and its salts.
f. 3,4 - methylenedioxyphenyl-2-propanone.
g. N-acetylanthranilic acid, its esters, and its salts.
h. Norpseudoephedrine, its salts, optical isomers, and salts
of optical isomers.
i. Phenylacetic acid, its esters, and its salts.
j. Piperidine and its salts.
k. Methylamine and its salts.
l. Propionic anhydride.
m. Isosafrole.
n. Safrole.
o. Piperonal.
p. N-methylephedrine, its salts, optical isomers, and salts
of optical isomers.
q. N-methylpseudoephedrine, its salts, optical isomers, and
salts of optical isomers.
r. Hydriodic acid.
s. Benzaldehyde.
t. Nitroethane.
u. Gamma-Butyrolactone (also known as
GBL; Dihydro-2(3H)-furanone; 1,2-Butanolide;
1,4-Butanolide; 4-Hydroxybutanoic acid lactone;
or gamma-hydroxy-butyric acid lactone).
v. Red phosphorus.
w. White phosphorus (another name: yellow phosphorus).
x. Hypophosphorous acid and its salts (including ammonium
hypophosphite, calcium hypophosphite, iron hypophosphite, potassium
hypophosphite, manganese hypophosphite, magnesium hypophosphite, and
sodium hypophosphite).
y. Iodine.
z. N-phenethyl-4-piperidone (NPP).
2. The board shall administer the regulatory provisions of this
chapter and may, by rule adopted pursuant to chapter 17A, add a
substance to or remove a substance from the list in subsection 1. In
determining whether to add or remove a substance from the list, the
board shall consider the following:
a. The likelihood that the substance may be used as a
precursor in the illegal production of a controlled substance.
b. The availability of the substance.
c. The appropriateness of including the substance under this
chapter or under chapter 124.
d. The extent and nature of legitimate uses for the
substance.
3. On or before November 1 of each year, the board shall inform
the general assembly of any substances added, deleted, or changed in
the list contained in this section and shall provide an explanation
of any addition, deletion, or change.
124B.2 REPORTING REQUIRED.
1. Effective July 1, 1990, a report to the board shall be
submitted in accordance with this chapter by a manufacturer,
retailer, or other person who sells, transfers, or otherwise
furnishes to any person in this state any of the following
substances:
a. Anthranilic acid, its esters, and its salts.
b. Benzyl cyanide.
c. Ethylamine and its salts.
d. Ergonovine and its salts.
e. Ergotamine and its salts.
f. 3,4 - methylenedioxyphenyl-2-propanone.
g. N-acetylanthranilic acid, its esters, and its salts.
h. Norpseudoephedrine, its salts, optical isomers, and salts
of optical isomers.
i. Phenylacetic acid, its esters, and its salts.
j. Piperidine and its salts.
k. Methylamine and its salts.
l. Propionic anhydride.
m. Isosafrole.
n. Safrole.
o. Piperonal.
p. N-methylephedrine, its salts, optical isomers, and salts
of optical isomers.
q. N-methylpseudoephedrine, its salts, optical isomers, and
salts of optical isomers.
r. Hydriodic acid.
s. Benzaldehyde.
t. Nitroethane.
u. Gamma-Butyrolactone (also known as
GBL; Dihydro-2(3H)-furanone; 1,2-Butanolide;
1,4-Butanolide; 4-Hydroxybutanoic acid lactone;
or gamma-hydroxy-butyric acid lactone).
v. Red phosphorus.
w. White phosphorus (another name: yellow phosphorus).
x. Hypophosphorous acid and its salts (including ammonium
hypophosphite, calcium hypophosphite, iron hypophosphite, potassium
hypophosphite, manganese hypophosphite, magnesium hypophosphite, and
sodium hypophosphite).
y. Iodine.
z. N-phenethyl-4-piperidone (NPP).
2. The board shall administer the regulatory provisions of this
chapter and may, by rule adopted pursuant to chapter 17A, add a
substance to or remove a substance from the list in subsection 1. In
determining whether to add or remove a substance from the list, the
board shall consider the following:
a. The likelihood that the substance may be used as a
precursor in the illegal production of a controlled substance.
b. The availability of the substance.
c. The appropriateness of including the substance under this
chapter or under chapter 124.
d. The extent and nature of legitimate uses for the
substance.
3. On or before November 1 of each year, the board shall inform
the general assembly of any substances added, deleted, or changed in
the list contained in this section and shall provide an explanation
of any addition, deletion, or change.
